| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/20/2008 | EP1888647A2 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38 |
| 02/20/2008 | EP1888646A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 02/20/2008 | EP1888645A2 Anti-cd16 binding molecules |
| 02/20/2008 | EP1888644A1 Anti-il2 antibodies |
| 02/20/2008 | EP1888643A2 Anti-gm-csf antibodies and uses therefor |
| 02/20/2008 | EP1888642A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof |
| 02/20/2008 | EP1888641A1 Serum albumin binding proteins |
| 02/20/2008 | EP1888640A2 Improved nanobodies against tumor necrosis factor-alpha |
| 02/20/2008 | EP1888639A1 Methods for damaging cells using effector function of anti-dsc2 antibody |
| 02/20/2008 | EP1888638A2 Method of producing antibodies with modified fucosylation level |
| 02/20/2008 | EP1888637A2 Compositions and methods for increasing the stability of antibodies |
| 02/20/2008 | EP1888636A2 Method for the purification of antibodies |
| 02/20/2008 | EP1888634A2 Mhc class i and ii peptide antigens derived from tumour antigen 5t4 |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1888113A2 Tweak binding antibodies |
| 02/20/2008 | EP1888109A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/20/2008 | EP1558741B1 Recombination of nucleic acid library members |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1121437B1 Metastatic breast and colon cancer regulated genes |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1072272B1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 02/20/2008 | EP1039873B1 Keratin-based hydrogel for biomedical applications and method of production |
| 02/20/2008 | EP0991945B2 Method for identification of tumor antigens with autoantibodies in serum |
| 02/20/2008 | EP0985039B1 Artificial antibody polypeptides |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0731806B2 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 02/20/2008 | CN101128586A Methods for producing soluble membrane-spanning proteins |
| 02/20/2008 | CN101128487A Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
| 02/20/2008 | CN101128486A Monoclonal antibodies against CD30 lacking in fucosyl residues |
| 02/20/2008 | CN101128485A Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128483A Antibodies directed to angiopoietin-2 and uses thereof |
| 02/20/2008 | CN101128215A Immunogenic composition for use in vaccination against staphylococcei |
| 02/20/2008 | CN101128207A Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 02/20/2008 | CN101126175A Method for screening and identifying monoclonal antibody by using bacteriophage exhibiting library |
| 02/20/2008 | CN101126081A Monoclonal antibody of antihuman substance metal protease and application thereof |
| 02/20/2008 | CN101125890A Monoclonal antibody for resisting bovine prion protein and application thereof |
| 02/20/2008 | CN101125889A Microcystin monoclonal antibody and its preparation method and application |
| 02/20/2008 | CN101125888A Expression production for recombination immunoglobulin capable of specifically identifying blood vessel endothelial cell growth factor and application thereof |
| 02/20/2008 | CN101125887A Method for preparing antiendotoxic Fab' |
| 02/20/2008 | CN101125886A Method for extracting yolk immunoglobulin |
| 02/20/2008 | CN100369934C Monoclonal antibody against human 4-1BBL and its use |
| 02/20/2008 | CN100369933C Preparation and use of monoclonal antibody against human GL50 |
| 02/20/2008 | CN100369932C Monoclonal antibody against human CD154 and its use |
| 02/20/2008 | CN100369931C Monoclonal antibody against human B7-1 molecule and its use |
| 02/20/2008 | CN100369930C Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | USRE40070 Antibody purification |
| 02/19/2008 | US7332595 DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 02/19/2008 | US7332587 Separation of target molecule from sample; obtain sample, incubate with oli bodies, isolate oil body bound target |
| 02/19/2008 | US7332585 Bispecific single chain Fv antibody molecules and methods of use thereof |
| 02/19/2008 | US7332584 Antibodies that specifically bind PMS2 |
| 02/19/2008 | US7332583 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/19/2008 | US7332582 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject |
| 02/19/2008 | US7332581 Polypeptide variants with altered effector function |
| 02/19/2008 | US7332580 Bispecific single chain Fv antibody molecules and methods of use thereof |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332578 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder |
| 02/19/2008 | US7332577 Active antithrombin content ranging from 0.03 to 0.10 mg/g of albumin, and a prekallikrein (PKA) activity that remains below 35 IU/ml over time; to increase blood volume in cardiovascular surgery |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332567 Fret protease assays for clostridial toxins |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | US7332333 Host cells containing multiple integrating vectors |
| 02/19/2008 | US7332316 Plant cytokinin oxidase |
| 02/19/2008 | US7332310 Mutant of homoserine dehydrogenase from Corynebacterium and DNA encoding thereof |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332291 identification of the natural ligand for the orphan G-Protein Coupled Receptor; diagnosis of conditions involving dysregulated receptor activity |
| 02/19/2008 | US7332287 Methods and compositions for diagnosing breast cancer |
| 02/19/2008 | US7332278 Detecting the activity of and screening acceptor substrates, inhibitors, or activators of enzymes catalyzing group transfer reactions to facilitate the development of more selective and therapeutic drugs |
| 02/19/2008 | US7332269 Hepatitis C virus (HCV) diagnosis kits wherein ability of proteins to bind anti-HCV murine antibodies has been removed; solid phase synthesis |
| 02/19/2008 | US7332168 Composition for the elimination of autoreactive B-cells |
| 02/19/2008 | US7332166 Glycosylated specificity exchangers |
| 02/19/2008 | US7332165 Antibody production in farm animals |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | US7332162 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 02/19/2008 | US7332157 Methods for human allografting |
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | CA2333747C Separation of protein monomers by use of ion-exchange chromatography |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor |
| 02/14/2008 | WO2008019379A2 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 02/14/2008 | WO2008019326A2 Ephb3-specific antibody and uses thereof |
| 02/14/2008 | WO2008019290A2 Human antibodies to erbb 2 |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008017859A2 Ligand for the g6b receptor on blood platelets |
| 02/14/2008 | WO2008017828A2 Antibodies specific for human cd98 heavy antigen |
| 02/14/2008 | WO2007141278A3 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof |
| 02/14/2008 | WO2007140371A3 Antibodies and immunoconjugates and uses therefor |
| 02/14/2008 | WO2007059715A8 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 02/14/2008 | WO2007058267A8 Novel protein and gene encoding the protein |
| 02/14/2008 | WO2007031875A3 Modified antigen binding molecules with altered cell signaling activity |
| 02/14/2008 | WO2007010283A8 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 02/14/2008 | WO2006048781A3 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 02/14/2008 | US20080040820 Nonhuman Animals for Antibody Production, and Methods and Systems for Producing Anitbodies Using Such Animals |
| 02/14/2008 | US20080039413 Novel compositions and methods in cancer |
| 02/14/2008 | US20080039411 Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |